Bordetella sp. Versus Microbiota

博德特氏菌属

基本信息

  • 批准号:
    8896095
  • 负责人:
  • 金额:
    $ 37.68万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2014
  • 资助国家:
    美国
  • 起止时间:
    2014-08-01 至 2016-07-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Although the interactions between invading pathogens and the host's resident microbiota are clearly important to the outcome of many infections, they remain poorly understood with few experimental systems in which they can be explored at a molecular mechanistic level. We have recently identified striking differences between closely related pathogens of the genus Bordetella in their interactions with host microbiome that can explain important aspects of their biology, including host specificity and pathology. B. bronchiseptica efficiently colonizes the upper respiratory tracts (URT) of mice (ID50<10cfu) and displaces the resident microflora in the process. B. pertussis, which causes highly contagious Whooping Cough in humans, poorly colonizes mice (ID50>1000cfu) and does not affect resident microbiota. Testing the hypothesis that resident microbiota of mice inhibit colonization, we observed that clearing the URT of bacteria allows B. pertussis to efficiently colonize (ID50<100). We have now extended this work by identifying specific microorganisms that can prevent B. pertussis colonization. This application will 1. Define the ability of resident microorganism(s) to inhibit B. pertussis colonization of mice, 2. Identify ecological mechanisms of competition amongst nasal microbiota and invading bordetellae, and 3. Determine the molecular mechanisms by which B. bronchiseptica clears microflora from the URT. This exceptionally powerful and tractable experimental system will allow us to study the complex interactions between invading pathogen and host resident microbiota to satisfying molecular mechanisms. Improved understanding of these interactions is likely to inform views of the many other mucosal pathogens for which there is not such a powerful host infection experimental system.
描述(由申请人提供):尽管入侵病原体与宿主常驻微生物群之间的相互作用对于许多感染的结果显然是重要的,但它们仍然知之甚少,很少有实验系统可以在分子机制水平上对其进行探索。我们最近发现了密切相关的博德特氏菌属病原体与宿主微生物组相互作用的显著差异,这些差异可以解释其生物学的重要方面,包括宿主特异性和病理学。B。支气管败血症有效地定植在小鼠的上呼吸道(URT)(ID50<10 cfu),并在此过程中取代了常驻微生物群落。B。百日咳在人类中引起高度传染性的百日咳,在小鼠中的定植很差(ID50>1000cfu),并且不影响常驻微生物群。测试小鼠的常驻微生物群抑制定殖的假设,我们观察到清除URT的细菌允许B。百日咳杆菌有效定殖(ID50<100)。我们现在通过鉴定可以预防B的特定微生物来扩展这项工作。百日咳定植。该应用程序将1。确定住院医师的能力 抑制B的微生物。小鼠的百日咳定殖,2.确定鼻微生物群和入侵的博德特氏菌之间竞争的生态机制,以及3。确定B.支气管败血症清除URT中的微生物。这种异常强大和易于处理的实验系统将使我们能够研究入侵病原体和宿主驻留微生物群之间的复杂相互作用,以满足分子机制。对这些相互作用的进一步了解可能会为许多其他粘膜病原体的观点提供信息,因为这些病原体没有如此强大的宿主感染实验系统。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Eric T Harvill其他文献

Eric T Harvill的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Eric T Harvill', 18)}}的其他基金

An air-liquid interface system to study Bordetella pertussis interactions with respiratory epithelia
研究百日咳博德特氏菌与呼吸道上皮细胞相互作用的气液界面系统
  • 批准号:
    10665943
  • 财政年份:
    2023
  • 资助金额:
    $ 37.68万
  • 项目类别:
Protection against Bordetella pertussis transmission conferred by established and novel vaccines
现有疫苗和新型疫苗可预防百日咳博德特氏菌传播
  • 批准号:
    10375566
  • 财政年份:
    2021
  • 资助金额:
    $ 37.68万
  • 项目类别:
Are acellular vaccines driving the rise of pertactin-deficient Bordetella pertussis
无细胞疫苗是否会导致缺乏百日咳博德特氏菌的增加
  • 批准号:
    10364771
  • 财政年份:
    2021
  • 资助金额:
    $ 37.68万
  • 项目类别:
Protection against Bordetella pertussis transmission conferred by established and novel vaccines
现有疫苗和新型疫苗可预防百日咳博德特氏菌传播
  • 批准号:
    10194677
  • 财政年份:
    2021
  • 资助金额:
    $ 37.68万
  • 项目类别:
12th International Symposium on Bordetella
第12届博德特氏菌国际研讨会
  • 批准号:
    9761709
  • 财政年份:
    2019
  • 资助金额:
    $ 37.68万
  • 项目类别:
12th International Bordetella Symposium
第十二届国际博德特氏菌研讨会
  • 批准号:
    9805872
  • 财政年份:
    2018
  • 资助金额:
    $ 37.68万
  • 项目类别:
In vivo vaccine-driven evolution in Bordetella pertussis
百日咳博德特氏菌体内疫苗驱动的进化
  • 批准号:
    8986495
  • 财政年份:
    2015
  • 资助金额:
    $ 37.68万
  • 项目类别:
Systematic evaluation of B. pertussis ACT’s role as a protective antigen
百日咳博德特氏菌 ACT 作为保护性抗原的作用的系统评估
  • 批准号:
    9056231
  • 财政年份:
    2015
  • 资助金额:
    $ 37.68万
  • 项目类别:
The Microbiota Pathogen Competition
微生物群病原体竞赛
  • 批准号:
    9291478
  • 财政年份:
    2015
  • 资助金额:
    $ 37.68万
  • 项目类别:
Evolution of the Bordetellae from Commensals to Pathogens
博德特氏菌从共生菌到病原体的进化
  • 批准号:
    7886472
  • 财政年份:
    2009
  • 资助金额:
    $ 37.68万
  • 项目类别:

相似海外基金

SPIDVAC - Improved control of priority animal diseases: Novel vaccines and companion diagnostic tests for African horse sickness, peste des petits ruminants and foot-and-mouth disease
SPIDVAC - 改善重点动物疾病的控制:针对非洲马病、小反刍兽疫和口蹄疫的新型疫苗和伴随诊断测试
  • 批准号:
    10043719
  • 财政年份:
    2022
  • 资助金额:
    $ 37.68万
  • 项目类别:
    EU-Funded
Improved control of priority animal diseases: Novel vaccines and companion diagnostic tests for African horse sickness, peste des petits ruminants and foot- and-mouth disease
改善重点动物疾病的控制:针对非洲马病、小反刍兽疫和口蹄疫的新型疫苗和伴随诊断测试
  • 批准号:
    10059336
  • 财政年份:
    2022
  • 资助金额:
    $ 37.68万
  • 项目类别:
    EU-Funded
Generation of transboundary animal diseases-resistant animals by genetic modification technologies to Rab-GTPases genes
利用Rab-GTP酶基因转基因技术培育跨境动物抗病动物
  • 批准号:
    20K20577
  • 财政年份:
    2020
  • 资助金额:
    $ 37.68万
  • 项目类别:
    Grant-in-Aid for Challenging Research (Pioneering)
Transmission: Astonishing Tales of Human-Animal Diseases
传播:人畜疾病的惊人故事
  • 批准号:
    9096618
  • 财政年份:
    2016
  • 资助金额:
    $ 37.68万
  • 项目类别:
13 Development of magnetometer immunoassay technology for the rapid and cost effective detection of endemic animal diseases and pathogens (zoonoses)
13 开发磁力计免疫测定技术,用于快速且经济有效地检测地方性动物疾病和病原体(人畜共患病)
  • 批准号:
    BB/L011360/1
  • 财政年份:
    2013
  • 资助金额:
    $ 37.68万
  • 项目类别:
    Research Grant
Development of magnetometer immunoassay (MIA) technology for the rapid and cost effective detection of endemic animal diseases and pathogens (zoonoses) in a decentralised, point of use, setting
开发磁力计免疫分析 (MIA) 技术,用于在分散的使用点环境中快速且经济高效地检测地方性动物疾病和病原体(人畜共患病)
  • 批准号:
    101466
  • 财政年份:
    2013
  • 资助金额:
    $ 37.68万
  • 项目类别:
    Collaborative R&D
Application of a lipocalin towards a biomarker for livestock animal diseases
脂质运载蛋白在畜牧动物疾病生物标志物中的应用
  • 批准号:
    25660216
  • 财政年份:
    2013
  • 资助金额:
    $ 37.68万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
Establishment of genetic engineering method for Pasteurellaceae bacteria from animal diseases.
动物疫病巴氏杆菌基因工程方法的建立
  • 批准号:
    22580359
  • 财政年份:
    2010
  • 资助金额:
    $ 37.68万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Practical control of pathogens which cases stock animal diseases
畜牧动物疾病病原体的实际控制
  • 批准号:
    21360399
  • 财政年份:
    2009
  • 资助金额:
    $ 37.68万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Environmental evaluation, practical use of the resources and investigation of the domestic animal diseases using the living body information of small antelopes in Africa
利用非洲小羚羊活体信息进行环境评价、资源实用化及家畜疾病调查
  • 批准号:
    21255010
  • 财政年份:
    2009
  • 资助金额:
    $ 37.68万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了